New Delhi, April 3 (NationPress) The Union Ministry of Health and Family Welfare has recognized the Jan Vishwas (Amendment of Provisions) Bill, 2026, which was recently approved by both Houses of Parliament, as a pivotal measure for enhancing public health.

This Bill amends 784 provisions across 79 Central Acts administered by 23 Ministries.

In the realm of public health, these amendments impact crucial laws, including the Drugs and Cosmetics Act of 1940, the Pharmacy Act of 1948, the Food Safety and Standards Act, the Clinical Establishments (Registration and Regulation) Act of 2010, and the National Commission for Allied and Healthcare Professions Act of 2021, as noted in the official statement.

The reforms aim to align with the overarching goal of simplifying compliance while ensuring strong protections for public health.

A standout aspect of these reforms is the replacement of criminal penalties, especially imprisonment for minor procedural infringements, with a system of graded monetary fines.

This shift indicates a transition towards a more facilitative regulatory environment while keeping stringent actions for serious violations that impact public health and safety.

Under the Drugs and Cosmetics Act of 1940, amendments have been made to replace imprisonment with financial penalties and to introduce a structured adjudication process, according to the statement.

Importantly, a new adjudication mechanism has been established for violations under Section 27A(ii) and Section 28A. This ensures that minor cosmetic violations (excluding spurious or adulterated products) can be resolved through civil penalties, eliminating the need for court involvement.

Additionally, violations such as the failure to maintain documents or submit information, which were previously subject to court-imposed fines or imprisonment, can now be resolved using this civil penalty framework.

For the first time, the legislation allows the appointment of adjudicating authorities by both the Central and State Governments, along with a defined procedure that includes the issuance of show-cause notices, personal hearings, and an appellate process.

This reform is expected to greatly alleviate the burden on courts, reduce layers of litigation, and facilitate quicker resolutions of minor compliance issues, as stated.

It will particularly aid the cosmetics industry by allowing for a structured, predictable approach to handling minor violations, such as procedural lapses like failure to maintain statutory records, thereby liberating them from extensive litigation.

Similarly, updates to the Pharmacy Act of 1948 seek to modernize penalty provisions and bolster accountability by increasing financial penalties for non-compliance, while ensuring conformity with updated legal frameworks.

Under the Food Safety and Standards Act of 2006, provisions have been revised to enhance enforcement while making sure that penalties are proportional to the nature of the offence, supporting a balanced approach between regulatory oversight and compliance ease.

The Clinical Establishments (Registration and Regulation) Act of 2010 has been updated to prioritize monetary penalties for non-compliance, especially in situations where deficiencies do not pose immediate risks to patient safety. This encourages corrective actions without resorting to criminal proceedings, according to the statement.

Furthermore, the National Commission for Allied and Healthcare Professions Act of 2021 has been reinforced to ensure adherence to professional standards and regulatory obligations, with penalties intended to deter violations while maintaining fairness.

The synchronization of these reforms across various health-related legislations demonstrates a cohesive policy strategy aimed at harmonizing regulatory frameworks.

By standardizing the transition from criminal penalties to civil penalties and introducing adjudication mechanisms, the amendments guarantee consistency, predictability, and proportionality in enforcement.

This alignment minimizes regulatory fragmentation, simplifies compliance mandates, and clarifies expectations for stakeholders operating in various areas of the health sector.